Equus Total Return gets NYSE notice on sub-$1.00 share price; weighs reverse split

EQUUS TOTAL RETURN, INC.

NYSE notified Equus on Oct 6, 2026 of non-compliance with Section 802.01C: 30-trading-day average closing price fell below the $1.00 minimum.
Equus plans to tell the NYSE by Oct 20, 2026 it will cure the deficiency; the cure window runs six months from the notice.
Remedies under consideration include a reverse stock split, which would require stockholder approval at a special meeting.
Common stock (NYSE: EQS) remains listed and trading during the cure period; company says operations and SEC reporting are unaffected.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.